Home Capital Group Inc.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, EQB.TO has a market cap of 3.9B. Regarding current trading prices, HCG.TO is priced at CA$44.27, while EQB.TO trades at CA$106.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas EQB.TO's P/E ratio is 17.79. In terms of profitability, HCG.TO's ROE is +0.10%, compared to EQB.TO's ROE of +0.07%. Regarding short-term risk, HCG.TO is less volatile compared to EQB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.Check EQB.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, FN.TO has a market cap of 2.9B. Regarding current trading prices, HCG.TO is priced at CA$44.27, while FN.TO trades at CA$47.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas FN.TO's P/E ratio is 15.63. In terms of profitability, HCG.TO's ROE is +0.10%, compared to FN.TO's ROE of +0.25%. Regarding short-term risk, HCG.TO is more volatile compared to FN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HCG.TO.Check FN.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, MKP.TO has a market cap of 910.7M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while MKP.TO trades at CA$22.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas MKP.TO's P/E ratio is 11.87. In terms of profitability, HCG.TO's ROE is +0.10%, compared to MKP.TO's ROE of +0.12%. Regarding short-term risk, HCG.TO is less volatile compared to MKP.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.Check MKP.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, DLCG.TO has a market cap of 620.7M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while DLCG.TO trades at CA$8.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas DLCG.TO's P/E ratio is -3.17. In terms of profitability, HCG.TO's ROE is +0.10%, compared to DLCG.TO's ROE of -0.85%. Regarding short-term risk, HCG.TO is less volatile compared to DLCG.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.Check DLCG.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, TF.TO has a market cap of 551.1M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while TF.TO trades at CA$6.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas TF.TO's P/E ratio is 15.86. In terms of profitability, HCG.TO's ROE is +0.10%, compared to TF.TO's ROE of +0.05%. Regarding short-term risk, HCG.TO is less volatile compared to TF.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.Check TF.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, AI.TO has a market cap of 543.1M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while AI.TO trades at CA$11.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas AI.TO's P/E ratio is 11.03. In terms of profitability, HCG.TO's ROE is +0.10%, compared to AI.TO's ROE of +0.09%. Regarding short-term risk, HCG.TO is less volatile compared to AI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.Check AI.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, FC.TO has a market cap of 429.8M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while FC.TO trades at CA$11.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas FC.TO's P/E ratio is 11.47. In terms of profitability, HCG.TO's ROE is +0.10%, compared to FC.TO's ROE of +0.09%. Regarding short-term risk, HCG.TO is less volatile compared to FC.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.Check FC.TO's competition here

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, STX.CN has a market cap of 2.6M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while STX.CN trades at CA$0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas STX.CN's P/E ratio is -0.29. In terms of profitability, HCG.TO's ROE is +0.10%, compared to STX.CN's ROE of -0.92%. Regarding short-term risk, HCG.TO is more volatile compared to STX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HCG.TO.Check STX.CN's competition here